3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Lymphoma
15
Neutropenia
9
Lymphoma, Large B-Cell, Diffuse
7
Leukemia
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Hodgkin Disease
4
Chemotherapy-induced Neutropenia
4
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Breast Neoplasms, Male
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma of Lung
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Interventions
fludarabine phosphate
28
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
19
Mycophenolic Acid
19
Methotrexate
15
Antilymphocyte Serum
13
Cyclosporine
12
Melphalan
9
Filgrastim
9
Cytarabine
9
Etoposide
8
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Thiotepa
6
Methylprednisolone
6
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
merphos
4
Sirolimus
4
Rituximab
4
Radiotherapy
4
Flow Cytometry
4
Dexamethasone
4
Dasatinib
4
Cyclosporins
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blast Crisis
×
pegfilgrastim
×
Clear all
No trials found.